Co-Diagnostics Inc (CODX) Stock Price, Quote & News

Company Profile

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus...

Industry: Medical Devices

Sector: Healthcare

Phone: 801 438 1036

Website: co-dx.com

Address:

2401 S. Foothill Dr., Suite D, Salt Lake City, United States

Love1010 Apr. 4 at 10:01 PM

$CODX does this ever go up

1 · Reply

Antiquarian Apr. 4 at 5:35 PM

$CODX

1 · Reply

Minutiae Apr. 3 at 10:52 PM

$CODX CDC Respiratory Virus Activity Levels Apr. 3, 2026 For Everyone Provides an update on how COVID-19, influenza, and RSV may be spreading nationally and in your state. https://www.cdc.gov/respiratory-viruses/data/activity-levels.html

0 · Reply

Ruddogg21 Apr. 3 at 7:31 PM

$CODX This Casino is Closing soon. I will sprinkle adds daily in honor of the Legend @Millones Cheers to a Co-Miracle

1 · Reply

LondonVentures Apr. 3 at 1:10 PM

$CODX https://www.sltrib.com/news/2026/04/02/measles-utah-cases-spike-outbreak/ Maybe we’ll see a new update on the website now that the mothership is at risk

1 · Reply

SmallPhish Apr. 3 at 9:45 AM

$CODX Is the company just dumping shares from an account controlled by the CFO, or are they paying a broker to handle the sales? I wonder what is the cost to publish a PR vs how many shares are dumped to raise cash?

1 · Reply

Minutiae Apr. 3 at 4:12 AM

$CODX Apr 2 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx

0 · Reply

Minutiae Apr. 3 at 4:11 AM

$CODX Apr 2 CODX volume 129,916 closing at $1.54. Chart begins just after 9:30 am to avoid premarket volume from overwhelming day trading volumes. 4,860 after-hour shares trading at $1.51 to $1.5881. FINRA Short Sale Volume 23,908 shorted shares out of 49,798. CODX short volume 48%. https://www.nasdaq.com/market-activity/stocks/codx/advanced-charting

1 · Reply

DiviDiVa20 Apr. 2 at 9:48 PM

$CODX just wow, all I got

0 · Reply

Minutiae Apr. 2 at 5:55 PM

$CODX Not long ago, the SEC proposed Rule 205 requiring a broker-dealer to mark a purchase order as “buy to cover”, information especially useful to the Commission in reconstructing significant market events and identifying potentially abusive trading practices. Rule 205 was never implemented. We have no way to track down those shorts who are illegally manipulating CODX share price downward to cover their short sales. We need that "buy to cover" marking rule to take down these criminal illegal short manipulators!!! SEC Proposes Short Sale Disclosure Rule, Order Marking Requirement, and CAT Amendments Feb. 25, 2022 https://www.sec.gov/newsroom/press-releases/2022-32 SEC Adopts New Short Sale Disclosure Rule Oct 24, 2023 "The SEC did not adopt proposed Rule 205 which would have required broker-dealers to mark purchase orders as “buy to cover” when purchasing to cover short positions." https://www.proskauer.com/alert/sec-adopts-new-short-sale-disclosure-rule SEC Adopts Rule Regarding Short Position and Short Activity Reporting 25 Oct 2023 https://www.debevoise.com/insights/publications/2023/10/sec-adopts-rule-regarding-short-position-and

1 · Reply

Co-Diagnostics Reports Full Year 2025 Financial Results

Mar 25, 2026, 8:00 AM EDT - 11 days ago

Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

Mar 25, 2026, 7:46 AM EDT - 11 days ago

EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch

Mar 20, 2026, 8:00 AM EDT - 16 days ago

Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia

Mar 20, 2026, 7:56 AM EDT - 16 days ago

EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity

Mar 17, 2026, 9:00 AM EDT - 18 days ago

Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast

Mar 16, 2026, 9:00 AM EDT - 19 days ago

Co-Diagnostics to Present at Medical Korea 2026

Mar 12, 2026, 9:00 AM EDT - 23 days ago

Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

Mar 10, 2026, 9:00 AM EDT - 25 days ago

Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements

Feb 9, 2026, 9:00 AM EST - 7 weeks ago

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

Feb 5, 2026, 9:00 AM EST - 2 months ago

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Feb 4, 2026, 9:00 AM EST - 2 months ago

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

Jan 12, 2026, 9:00 AM EST - 2 months ago

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

Dec 30, 2025, 9:00 AM EST - 3 months ago

Co-Diagnostics Announces Reverse Stock Split

Dec 29, 2025, 9:00 AM EST - 3 months ago

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

Dec 18, 2025, 9:00 AM EST - 3 months ago

Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India

Dec 17, 2025, 9:00 AM EST - 3 months ago

Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation

Dec 9, 2025, 9:00 AM EST - 4 months ago

Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025

Dec 8, 2025, 12:36 PM EST - 4 months ago

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Nov 20, 2025, 9:00 AM EST - 4 months ago

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health

Nov 18, 2025, 9:00 AM EST - 4 months ago

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

Nov 13, 2025, 4:01 PM EST - 5 months ago

Co-Diagnostics Reports Third Quarter 2025 Financial Results

Nov 5, 2025, 9:00 AM EST - 5 months ago

Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd

Nov 3, 2025, 9:00 AM EST - 5 months ago

Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

Oct 31, 2025, 9:00 AM EDT - 5 months ago

Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast

Oct 30, 2025, 1:57 PM EDT - 5 months ago

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

Oct 29, 2025, 12:51 PM EDT - 5 months ago

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 28, 2025, 9:33 AM EDT - 5 months ago

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 22, 2025, 8:30 AM EDT - 5 months ago

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia

Oct 16, 2025, 9:30 AM EDT - 6 months ago

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing

Oct 13, 2025, 9:30 AM EDT - 6 months ago

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

Sep 30, 2025, 9:30 AM EDT - 6 months ago

Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30

Sep 18, 2025, 5:05 PM EDT - 7 months ago

Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Sep 17, 2025, 9:47 AM EDT - 7 months ago

Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Sep 11, 2025, 9:30 AM EDT - 7 months ago

Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains

Sep 9, 2025, 9:30 AM EDT - 7 months ago

Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit

Aug 18, 2025, 9:30 AM EDT - 8 months ago

Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.

Aug 14, 2025, 4:01 PM EDT - 8 months ago

Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results

Jul 31, 2025, 9:30 AM EDT - 8 months ago

Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast

Jul 15, 2025, 9:30 AM EDT - 9 months ago

Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025

May 14, 2025, 9:30 AM EDT - 11 months ago

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference

May 8, 2025, 4:01 PM EDT - 11 months ago

Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results

Apr 29, 2025, 7:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast

Mar 27, 2025, 4:01 PM EDT - 1 year ago

Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results

Mar 13, 2025, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast

Mar 3, 2025, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025

Feb 24, 2025, 8:18 AM EST - 1 year ago

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version

Feb 21, 2025, 4:00 PM EST - 1 year ago

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance

Jan 7, 2025, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025

Dec 10, 2024, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility

Love1010 Apr. 4 at 10:01 PM

$CODX does this ever go up

1 · Reply

Antiquarian Apr. 4 at 5:35 PM

$CODX

1 · Reply

Minutiae Apr. 3 at 10:52 PM

0 · Reply

Ruddogg21 Apr. 3 at 7:31 PM

$CODX This Casino is Closing soon. I will sprinkle adds daily in honor of the Legend @Millones Cheers to a Co-Miracle

1 · Reply

LondonVentures Apr. 3 at 1:10 PM

$CODX https://www.sltrib.com/news/2026/04/02/measles-utah-cases-spike-outbreak/ Maybe we’ll see a new update on the website now that the mothership is at risk

1 · Reply

SmallPhish Apr. 3 at 9:45 AM

1 · Reply

Minutiae Apr. 3 at 4:12 AM

$CODX Apr 2 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx

0 · Reply

Minutiae Apr. 3 at 4:11 AM

1 · Reply

DiviDiVa20 Apr. 2 at 9:48 PM

$CODX just wow, all I got

0 · Reply

Minutiae Apr. 2 at 5:55 PM

1 · Reply

Antiquarian Apr. 2 at 4:40 PM

$CODX I wonder if Comira ever filled that “technical manager” position…….

0 · Reply

Millones Apr. 2 at 4:32 PM

$CODX Trickling out these little sound bits from the silicon slopes 2026 Nasdaq interview that shareholders aren’t privy to hear the enter thing yet… https://www.youtube.com/watch?v=74lbutw2L0U

1 · Reply

diamondhope Apr. 2 at 4:11 PM

$CODX imo Words, fast and loose money, for the chosen. Turds, no golden goose Honey, we be closin'.

1 · Reply

Minutiae Apr. 2 at 3:32 PM

$CODX Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City (PRNewsfoto/Co-Diagnostics) News provided by Co-Diagnostics Apr 02, 2026, 09:00 ET https://www.prnewswire.com/news-releases/co-diagnostics-joint-venture-comira-receives-approval-for-manufacturing-facility-in-kingdom-of-saudi-arabias-sudair-industrial-city-302732479.html

1 · Reply

Millones Apr. 2 at 2:13 PM

$CODX $0.04 pre reverse split achieved today. Nice

3 · Reply

STACKD0E Apr. 2 at 1:35 PM

$CODX $DCOY ✨

0 · Reply

SmallPhish Apr. 2 at 1:25 PM

$CODX Here’s what CFO Brian is doing right now

1 · Reply

Pyranha Apr. 2 at 1:22 PM

$CODX did anyone notice he didn’t mention South Africa this time? I.e SAFRA

1 · Reply

Millones Apr. 2 at 1:13 PM

$CODX https://ir.co-dx.com/2026-04-02-Co-Diagnostics-Joint-Venture-CoMira-Receives-Approval-for-Manufacturing-Facility-in-Kingdom-of-Saudi-Arabias-Sudair-Industrial-City Be careful with the news…

1 · Reply

DARKP00L Apr. 2 at 1:13 PM

$CODX 09:11 on Apr. 02 2026 Co-Diagnostics JV CoMira Secures Industrial Land Allocation In Sudair Industrial City In Riyadh Region #tradeideas

0 · Reply

Stock_Catcher Apr. 2 at 1:04 PM

$CODX Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial

0 · Reply

Millones Apr. 2 at 11:54 AM

$CODX Short sale restricted today, not that it has ever mattered https://www.nasdaqtrader.com/dynamic/symdir/shorthalts/shorthalts20260402.txt

0 · Reply

Market Cap	3.23M
Revenue (ttm)	3.92M
Net Income (ttm)	-37.64M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-960.20%
Debt to Equity Ratio	0.00

Volume	129,900
Avg Vol	1,426,076
Day's Range	N/A - N/A
Shares Out	2.10M
Stochastic %K	8%
Beta	1.42
Analysts	Hold
Price Target	$45.00